Marshall Wace, LLP Revolution Medicines, Inc. Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 1,504,801 shares of RVMD stock, worth $57.3 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,504,801
Previous 1,064,999
41.3%
Holding current value
$57.3 Million
Previous $48.3 Million
36.4%
% of portfolio
0.08%
Previous 0.06%
Shares
10 transactions
Others Institutions Holding RVMD
# of Institutions
298Shares Held
168MCall Options Held
920KPut Options Held
1.06M-
Vanguard Group Inc Valley Forge, PA17.1MShares$651 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$511 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.2MShares$505 Million3.09% of portfolio
-
Janus Henderson Group PLC London, X09.48MShares$361 Million0.22% of portfolio
-
Baker Bros. Advisors LP New York, NY7.94MShares$302 Million3.85% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.34B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...